Drug Reference
Glucosamine
Other antiinflammatory and antirheumatic agents, non-steroids
Rx only
Fact box
- Therapeutic class
- Other antiinflammatory and antirheumatic agents, non-steroids
- Habit forming
- No
- Availability
- Prescription (Rx)
Brand names
CidaflexCosaminNovipet Joint SupportNovipet Magic BitesOptiflex-GOsteo Bi-FlexSchiff
Available as
200 MG · Oral Tablet400 MG · Extended Release Oral Tablet133 MG · Oral Capsule500 UNT · Oral Tablet1200 MG · Oral Tablet500 MG · Oral Tablet40 MG/ML · Oral Solution400 MG · Oral Tablet50 MG · Chewable Tablet750 MG · Oral Tablet500 MG · Oral Capsule150 MG · Oral Tablet500 MG · Chewable Tablet600 MG · Chewable Tablet40 MG/ML · Oral Suspension250 MG · Oral Capsule400 MG · Oral Capsule200 MG · Extended Release Oral Tablet200 MG · Oral Capsule2000 MG · Oral Capsule1200 MG · Oral Capsule750 MG · Oral Capsule1500 MG · Oral Tablet400 MG · Chewable Tablet
FDA label sections are from openFDA and may not reflect the most recent labeling — confirm against the current DailyMed label.
⚠ Boxed warning
WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. KEEP THIS PRODUCT OUT OF REACH OF CHILDREN . In case of accidental overdose, call a doctor or poison control center immediately.
WARNING: Ingestion of more than 3 grams of omega-3 fatty acids (such as DHA) per day has been shown to have potential antithrombotic effects, including an increased bleeding time and International Normalized Ratio (INR). Administration of omega-3 fatty acids should be avoided in patients taking anticoagulants and in those known to have an inherited or acquired predisposition to bleeding.
WARNING: Ingestion of more than 3 grams of omega-3 fatty acids (such as DHA) per day has been shown to have potential antithrombotic effects, including an increased bleeding time and International Normalized Ratio (INR). Administration of omega-3 fatty acids should be avoided in patients taking anticoagulants and in those known to have an inherited or acquired predisposition to bleeding.
Uses
INDICATIONS: Chromagen™ is a multivitamin/multimineral dietary supplement indicated for use in improving the nutritional status of patients with iron deficiency.
How to use / dosing
DOSAGE AND ADMINISTRATION: One softgel daily, or as directed by a physician.
Side effects
ADVERSE REACTIONS: Allergic sensitization has been reported following both oral and parenteral administration of folic acid.
Safety advice
Conservative summary derived from FDA labeling — defaults to “consult your doctor” unless the label is explicit. Not a substitute for your clinician’s advice.
PregnancyNo information
No specific information in the FDA label.
BreastfeedingNo information
No specific information in the FDA label. Check LactMed →
AlcoholNo information
No specific information in the FDA label.
DrivingNo information
No specific information in the FDA label.
KidneyNo information
No specific information in the FDA label.
LiverNo information
No specific information in the FDA label.
Contraindications
CONTRAINDICATIONS : Chromagen™ is contraindicated in patients with a known hypersensitivity to any of the ingredients.
Current FDA labels (DailyMed)
- ELAIMEI BEE VENOM CREAM (BEE VENOM) CREAM [SHENZHEN SHANDIAN JINGLING TECHNOLOGY CO., LTD.]
- THERAFLEX ADVANCE (IBUPROFEN, GLUCOSAMINE SULFATE, AND CHONDROITIN SULFATE (BOVINE)) TABLET [BAYER HEALTHCARE LLC.]
- A-L-O LIQUID DROPS 2082 (A-L-O LIQUID DROPS) LIQUID [PROFESSIONAL COMPLEMENTARY HEALTH FORMULAS]
- CONNECTIVE TISSUE LIQUESCENCE 3024 (CONNECTIVE TISSUE LIQUESCENCE) LIQUID [PROFESSIONAL COMPLEMENTARY HEALTH FORMULAS]
- MUSCLE/LIGAMENT/CARTILAGE DROPS 5015 (MUSCLE/LIGAMENT/CARTILAGE DROPS) LIQUID [PROFESSIONAL COMPLEMENTARY HEALTH FORMULAS]
Authoritative sources
Reference only — not clinical advice. Verify against current FDA labeling and consult a licensed provider. About half of pediatric drug use is off-label and is not reflected in FDA labels; absence of pediatric information does not mean a medicine is unused or unsafe in children.